Press release
Rise In Infectious Diseases Fueling The Growth Of The Market Due To Increasing Transmission In Overcrowded Urban Areas: Core Growth Enabler in the Norovirus Treatment Market, 2025
Norovirus Treatment
What Will the Norovirus Treatment Industry Market Size Be by 2025?
Over the past few years, the market for norovirus treatment has seen significant expansion. The market is projected to grow from a worth of $1.75 billion in 2024 to $1.94 billion in 2025, experiencing a compound annual growth rate (CAGR) of 11.0%. Factors contributing to this growth during the historic period include a rise in worldwide norovirus outbreaks, increased public knowledge, an amplified emphasis on supportive care, investment in vaccine research, enhancements in healthcare infrastructure, and an increased need for efficient infection control strategies.
What's the Long-Term Growth Forecast for the Norovirus Treatment Market Size Through 2029?
The market for norovirus treatment is anticipated to experience swift expansion in the coming years, growing to $2.91 billion by 2029 with a compound annual growth rate (CAGR) of 10.7%. This predicted growth during the forecast period is due to reasons such as increased investment in antiviral drug research, the rising use of quick diagnostic instruments, increased understanding of the public health consequences related to norovirus, wider healthcare coverage in developing nations, and the creation of innovative therapies to address symptom severities. Looking ahead, trends include breakthroughs in vaccine research, pioneering antiviral treatments, advancements in molecular diagnostic methods, utilization of AI-powered diagnostic equipment, amplified public health outreach efforts, and creation of affordable, point-of-care treatment options.
View the full report here:
https://www.thebusinessresearchcompany.com/report/norovirus-treatment-global-market-report
What Are the Key Growth Drivers Fueling the Norovirus Treatment Market Expansion?
The rise in infectious diseases is likely to drive the expansion of the norovirus treatment market. Illnesses caused by bacteria, viruses, fungi, or parasites such as influenza, tuberculosis, HIV/AIDS, malaria, and norovirus are considered infectious diseases which are on the rise due to urban overcrowding. This leads to the enhanced speed of pathogen spread among highly populated areas. The intervention of norovirus treatment assists in minimizing the effects of infectious diseases through effective symptom management and curtailing contagion by maintaining proper hydration, hygiene, and isolation. As reported by the World Health Organization, a Switzerland-based intergovernmental body, in March 2025, approximately 10.8 million individuals globally, including 6.0 million men, 3.6 million women, and 1.3 million children, were diagnosed with tuberculosis in 2023. Hence, this uptick in infectious diseases is fueling the growth of the norovirus treatment market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24629&type=smp
What Are the Key Trends Driving Norovirus Treatment Market Growth?
Pioneering businesses in the norovirus treatment market are concentrating on crafting groundbreaking solutions, for instance, advanced mRNA vaccines aiming to expedite the formation of precise immunization, elevate defense against severe contagions, and decrease the international impact of norovirus-associated diseases. Advanced mRNA vaccines are progressive immunizations employing specially designed messenger RNA to direct cells to generate certain proteins, which activate a targeted immune response with superior stability, efficiency, and versatility against various infectious diseases. For example, in October 2024, Moderna Inc., a biotechnology firm based in the US, collaborated with the UK Health Security Agency (UKHSA), a government agency in the UK, to commence the first Phase 3 trial of an mRNA norovirus vaccine (mRNA-1403) globally. This trial brings forth a vaccine projected to counteract the extremely infectious norovirus by guiding the body to generate viral proteins that incite a robust immune response without using the live virus. Distinguishing characteristics of the launch comprise its utilization of stabilized mRNA for enhanced durability, prompt development potential in reaction to mutating strains, and the capacity to stimulate both antibody and T-cell responses.
How Is the Norovirus Treatment Market Segmented?
The norovirus treatment market covered in this report is segmented -
1) By Treatment: Electrolytes, Intravenous Fluids, Antipyretics, Analgesics, Anti-Diarrheal, Other Treatments
2) By Diagnosis: Bacteria Culture Test, Stool Tests, Other Diagnosis
3) By Route Of Administration: Oral, Intravenous, Subcutaneous
4) By End User: Hospitals, Clinics, Homecare Settings
Subsegments:
1) By Electrolytes: Oral Rehydration Salts (ORS), Sports Drinks, Pediatric Electrolyte Solutions
2) By Intravenous Fluids: Crystalloids, Colloids, Lactated Ringer's Solution
3) By Antipyretics: Acetaminophen (Paracetamol), Ibuprofen, Aspirin
4) By Analgesics: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioid Analgesics, Acetaminophen-Based Analgesics
5) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, Diphenoxylate-Atropine
6) By Other Treatments: Antiemetics, Probiotics, Zinc Supplements
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24629&type=smp
Which Companies Are Leading the Charge in Norovirus Treatment Market Innovation?
Major companies operating in the norovirus treatment market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, AstraZeneca plc, GSK plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Sun Pharmaceutical Industries Ltd., Lupin Ltd., Aurobindo Pharma Limited, Cipla Inc., Endo International plc.
Which Regions Are Leading the Global Norovirus Treatment Market in Revenue?
North America was the largest region in the norovirus treatment market in 2024. The regions covered in the norovirus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report to*day:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24629
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rise In Infectious Diseases Fueling The Growth Of The Market Due To Increasing Transmission In Overcrowded Urban Areas: Core Growth Enabler in the Norovirus Treatment Market, 2025 here
News-ID: 4092466 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
